Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind Study of the Effect of Oral Monthly Bonviva on in Vivo Bone Micro-Architecture Parameters in Post-Menopausal Women With Osteopenia.

Trial Profile

A Randomized, Double-Blind Study of the Effect of Oral Monthly Bonviva on in Vivo Bone Micro-Architecture Parameters in Post-Menopausal Women With Osteopenia.

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Ibandronic acid (Primary)
  • Indications Bone resorption
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.
    • 26 May 2010 Status changed from active, no longer recruiting to completed as reported by Roche record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top